echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Significant progress has been made in the research of swimming micro-nano robots in the treatment of gliomas

    Significant progress has been made in the research of swimming micro-nano robots in the treatment of gliomas

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Chinese scholars have made important progress in the research of swimming micro-nano robots in the treatment of gliomas
    Chinese scholars have made important progress in the research of swimming micro-nano robots in the treatment of glioma Chinese scholars have made important progress in the research of swimming micro-nano robots in the treatment of gliomas

    China News Service, Harbin, March 29 (Zhang Yifang, reporter Shi Yifu) Harbin Institute of Technology announced on the 29th that the research team of Professor He Qiang and Professor Wu Zhiguang from the Micro and Nano Technology Research Center of the school has realized the first time that swimming micro and nano robots can treat brain gliomas.


    Glioblastoma (GBM) is one of the most difficult to treat cancers.


    How to make drugs break through the blood-brain barrier, achieve active targeted delivery of drugs, and improve the efficacy of drugs on gliomas has become a bottleneck problem in the medical field of gliomas for a long time.


    In response to this problem, the research team has developed a swimming micro-nano robot (Neutrobot) based on immune cells in the body, which is prepared by neutrophils phagocytosing E.


    The swimming micro/nano robot can effectively and stably carry paclitaxel and other anti-cancer drugs, and rely on the self-developed control system to guide the swimming micro/nano robot to the brain area.


    These research results establish a swimming micro-nano robot based on immune cells as a potential precision therapy for glioma for the systemic treatment of glioma.


    The research results were published online in the journal Science Robotics with the title "Dual-responsive biohybridneutrobots for active target delivery" (Dual-responsive biohybridneutrobots for active target delivery).


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.